{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T09:15:45Z","timestamp":1780910145082,"version":"3.54.1"},"reference-count":8,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jaad.2025.09.006","type":"journal-article","created":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T10:00:06Z","timestamp":1757757606000},"page":"449-450","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Letter from the editor: Risks of hepatitis reactivation with biologics"],"prefix":"10.1016","volume":"94","author":[{"given":"Dirk M.","family":"Elston","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jaad.2025.09.006_bib1","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/RHU.0000000000000536","article-title":"Retrospective study of patients on etanercept therapy for rheumatic diseases in patients with chronic hepatitis C virus","volume":"23","author":"Gandhi","year":"2017","journal-title":"J Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.jaad.2025.09.006_bib2","first-page":"159","article-title":"Safety of etanercept in the treatment of rheumatic disease patients with hepatitis C virus infection","volume":"43","author":"Teixeira","year":"2018","journal-title":"Acta Reumatol Port"},{"issue":"44","key":"10.1016\/j.jaad.2025.09.006_bib3","doi-asserted-by":"crossref","first-page":"7867","DOI":"10.3748\/wjg.v19.i44.7867","article-title":"Tumor necrosis factor-\u03b1 inhibitors and chronic hepatitis C: a comprehensive literature review","volume":"19","author":"Pompili","year":"2013","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.jaad.2025.09.006_bib4","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1053\/j.gastro.2024.11.008","article-title":"AGA clinical practice guideline on the prevention and treatment of hepatitis B virus reactivation in at-risk individuals","volume":"168","author":"Ali","year":"2025","journal-title":"Gastroenterology"},{"issue":"28","key":"10.1016\/j.jaad.2025.09.006_bib5","doi-asserted-by":"crossref","first-page":"6444","DOI":"10.3748\/wjg.v22.i28.6444","article-title":"Management of psoriasis patients with hepatitis B or hepatitis C virus infection","volume":"22","author":"Bonifati","year":"2016","journal-title":"World J Gastroenterol"},{"issue":"5","key":"10.1016\/j.jaad.2025.09.006_bib6","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1517\/14712598.2015.1011616","article-title":"Current evidence in the field of the management with TNF-\u03b1 inhibitors in psoriatic arthritis and concomitant hepatitis C virus infection","volume":"15","author":"Caso","year":"2015","journal-title":"Expert Opin Biol Ther"},{"issue":"2","key":"10.1016\/j.jaad.2025.09.006_bib7","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3899\/jrheum.130658","article-title":"Safety of etanercept and methotrexate in patients with rheumatoid arthritis and hepatitis C virus infection: a multicenter randomized clinical trial","volume":"41","author":"Iannone","year":"2014","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.jaad.2025.09.006_bib8","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/BOR.0b013e328338f6df","article-title":"The A, B, Cs of viral hepatitis in the biologic era","volume":"22","author":"Ferri","year":"2010","journal-title":"Curr Opin Rheumatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962225027884?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962225027884?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T08:56:47Z","timestamp":1780909007000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962225027884"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":8,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0190962225027884"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2025.09.006","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Letter from the editor: Risks of hepatitis reactivation with biologics","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2025.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2025.09.030","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}